Ambev just upgraded at Morgan Stanley, here’s why

Morgan Stanley upgraded Ambev to Equal Weight from Underweight with a price target of R$15, up from R$13.50, following significant share price underperformance over the past year. However, the firm notes that its AlphaWise survey provides evidence that the competitive dynamics remain challenging in Brazil, which keeps it from a more bullish stance when coupled with Argentina and tax risks.